Related Experiment Video

Updated: Dec 25, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.4K

Kruppel-like factor 2 disturb non-small cell lung cancer energy metabolism by inhibited glutamine consumption

Song Xiao1, Yan Jin-Xiang2, Tian Long1

  • 1Radiotherapy Department, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.

The Journal of Pharmacy and Pharmacology
|March 21, 2020
PubMed
Abstract

Insights

Kruppel-like factor 2 (KLF2) inhibits non-small cell lung cancer (NSCLC) cell energy metabolism by reducing glutamine consumption. KLF2 impacts glutaminase expression, crucial for this metabolic effect in NSCLC.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Biology

Background:

  • Metabolic reprogramming is a key characteristic of cancer.
  • Understanding cancer cell energy metabolism is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of Kruppel-like factor 2 (KLF2) in aerobic glycolysis and glutamine consumption in non-small cell lung cancer (NSCLC) energy metabolism.
  • To elucidate the molecular mechanisms by which KLF2 influences NSCLC cell metabolism.

Main Methods:

  • Utilized two NSCLC cell lines (A549 and NCI-H1299).
  • Employed tracer techniques and KLF2 transfection to study glycolysis and glutamine consumption.
  • Investigated the effect of glutamine deprivation and glutaminase (GLS) inhibitors on KLF2-overexpressing cells.

Main Results:

  • Overexpression of KLF2 inhibited NSCLC cell energy metabolism and proliferation.
  • KLF2 primarily affected glutamine consumption, with no significant impact on glycolysis.
  • The inhibitory effects of KLF2 were dependent on glutamine availability and GLS expression, as KLF2 was found to inhibit GLS expression.

Conclusions:

  • Kruppel-like factor 2 (KLF2) plays a significant role in regulating NSCLC cell metabolism.
  • KLF2 reduces glutamine levels and consumption, thereby inhibiting cancer cell energy metabolism.
  • Targeting KLF2 or its downstream pathways, like GLS, may offer therapeutic strategies for NSCLC.
Keywords:
KLF2NSCLCaerobic glycolysisglutaminaseglutamine consumption

More Related Videos

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts06:32

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Published on: April 13, 2022

2.0K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

113.4K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K